ICD Co., Ltd. Logo

ICD Co., Ltd.

040910.KQ

(0.0)
Stock Price

5.690,00 KRW

-11.86% ROA

-28.98% ROE

-5.83x PER

Market Cap.

159.305.303.800,00 KRW

1.34% DER

1.1% Yield

-65.43% NPM

ICD Co., Ltd. Stock Analysis

ICD Co., Ltd. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

ICD Co., Ltd. Fundamental Stock Analysis
# Analysis Rating
1 ROE

Unidentified ROE

2 ROA

Unidentified ROA

3 PBV

Unidentified ROA

4 DER

Unidentified DER

5 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

6 Net Profit Growth

Despite the passage of five years, this company's net profit has not shown any improvement, highlighting a lack of growth and making it a less appealing investment prospect.

7 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

8 Graham Number

Unidentified Graham Number

9 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

10 Dividend

Investors should be cautious as the company hasn't distributed dividends in the last three years, possibly indicating financial challenges.

11 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is overpriced (0), presenting a possible disadvantage for investors as its market price surpasses its estimated intrinsic value.

ICD Co., Ltd. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

ICD Co., Ltd. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Hold

ICD Co., Ltd. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

ICD Co., Ltd. Revenue
Year Revenue Growth
2012 81.236.541.581
2013 81.040.018.921 -0.24%
2015 72.060.517.440 -12.46%
2016 230.909.153.870 68.79%
2017 311.847.747.950 25.95%
2018 233.974.936.900 -33.28%
2019 121.604.632.070 -92.41%
2020 308.965.253.530 60.64%
2021 115.769.377.770 -166.88%
2022 150.944.906.360 23.3%
2023 33.588.556.600 -349.39%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

ICD Co., Ltd. Research and Development Expenses
Year Research and Development Expenses Growth
2012 0
2013 0 0%
2015 44.872.000 100%
2016 913.566.000 95.09%
2017 840.062.000 -8.75%
2018 366.079.000 -129.48%
2019 1.598.900.000 77.1%
2020 661.428.000 -141.73%
2021 1.256.225.000 47.35%
2022 1.270.426.000 1.12%
2023 600.620.000 -111.52%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

ICD Co., Ltd. General and Administrative Expenses
Year General and Administrative Expenses Growth
2012 0
2013 0 0%
2015 119.820.000 100%
2016 303.445.000 60.51%
2017 268.987.000 -12.81%
2018 162.480.000 -65.55%
2019 138.566.000 -17.26%
2020 156.794.000 11.63%
2021 124.854.000 -25.58%
2022 153.084.000 18.44%
2023 180.372.000 15.13%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

ICD Co., Ltd. EBITDA
Year EBITDA Growth
2012 15.710.134.317
2013 12.168.248.767 -29.11%
2015 8.328.546.600 -46.1%
2016 20.371.176.440 59.12%
2017 42.896.248.320 52.51%
2018 45.820.094.410 6.38%
2019 20.694.194.950 -121.42%
2020 56.822.524.560 63.58%
2021 8.730.883.650 -550.82%
2022 1.437.832.160 -507.23%
2023 -18.295.653.600 107.86%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

ICD Co., Ltd. Gross Profit
Year Gross Profit Growth
2012 19.701.101.469
2013 19.495.016.157 -1.06%
2015 12.456.599.600 -56.5%
2016 30.197.627.320 58.75%
2017 55.601.508.320 45.69%
2018 58.035.086.870 4.19%
2019 34.239.904.510 -69.5%
2020 83.830.469.190 59.16%
2021 23.531.762.090 -256.24%
2022 15.883.134.730 -48.16%
2023 -15.365.925.120 203.37%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

ICD Co., Ltd. Net Profit
Year Net Profit Growth
2012 9.635.018.787
2013 7.220.171.321 -33.45%
2015 5.413.043.360 -33.38%
2016 10.353.732.870 47.72%
2017 24.491.203.340 57.72%
2018 29.833.629.810 17.91%
2019 11.151.768.510 -167.52%
2020 33.458.702.980 66.67%
2021 761.807.950 -4292.01%
2022 -5.419.301.450 114.06%
2023 -18.401.044.360 70.55%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

ICD Co., Ltd. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2012 586
2013 444 -31.98%
2015 336 -32.54%
2016 653 48.7%
2017 1.412 53.75%
2018 1.770 20.23%
2019 701 -152.5%
2020 1.974 64.49%
2021 45 -4286.67%
2022 -339 113.27%
2023 -1.140 70.26%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

ICD Co., Ltd. Free Cashflow
Year Free Cashflow Growth
2012 -837.803.067
2013 32.000.519.106 102.62%
2015 1.467.843.160 -2080.1%
2016 -23.089.999.080 106.36%
2017 -16.352.693.750 -41.2%
2018 26.064.805.450 162.74%
2019 22.901.144.990 -13.81%
2020 46.914.936.580 51.19%
2021 17.257.533.940 -171.85%
2022 -22.861.779.590 175.49%
2023 -5.677.953.080 -302.64%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

ICD Co., Ltd. Operating Cashflow
Year Operating Cashflow Growth
2012 -837.803.067
2013 32.000.519.106 102.62%
2015 8.817.099.640 -262.94%
2016 -9.107.735.080 196.81%
2017 -11.883.556.750 23.36%
2018 29.834.566.250 139.83%
2019 23.965.782.110 -24.49%
2020 49.529.874.170 51.61%
2021 21.230.361.670 -133.3%
2022 -14.294.360.680 248.52%
2023 -3.516.761.260 -306.46%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

ICD Co., Ltd. Capital Expenditure
Year Capital Expenditure Growth
2012 0
2013 0 0%
2015 7.349.256.480 100%
2016 13.982.264.000 47.44%
2017 4.469.137.000 -212.86%
2018 3.769.760.800 -18.55%
2019 1.064.637.120 -254.09%
2020 2.614.937.590 59.29%
2021 3.972.827.730 34.18%
2022 8.567.418.910 53.63%
2023 2.161.191.820 -296.42%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

ICD Co., Ltd. Equity
Year Equity Growth
2012 97.608.709.814
2013 105.421.051.635 7.41%
2015 88.874.078.500 -18.62%
2016 112.690.839.900 21.13%
2017 134.140.403.750 15.99%
2018 131.398.547.549 -2.09%
2019 147.055.395.970 10.65%
2020 179.473.878.470 18.06%
2021 167.936.709.850 -6.87%
2022 153.246.033.980 -9.59%
2023 151.998.317.410 -0.82%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

ICD Co., Ltd. Assets
Year Assets Growth
2012 117.738.561.807
2013 124.274.685.513 5.26%
2015 106.330.629.530 -16.88%
2016 241.202.452.410 55.92%
2017 236.230.285.570 -2.1%
2018 191.224.176.540 -23.54%
2019 203.772.358.060 6.16%
2020 233.099.358.270 12.58%
2021 232.848.927.880 -0.11%
2022 202.500.364.340 -14.99%
2023 214.865.272.500 5.75%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

ICD Co., Ltd. Liabilities
Year Liabilities Growth
2012 20.129.851.993
2013 18.853.633.878 -6.77%
2015 17.456.551.040 -8%
2016 128.511.612.510 86.42%
2017 102.089.881.820 -25.88%
2018 59.825.628.990 -70.65%
2019 56.716.962.090 -5.48%
2020 53.625.479.800 -5.76%
2021 64.912.218.030 17.39%
2022 49.254.330.350 -31.79%
2023 62.866.955.080 21.65%

ICD Co., Ltd. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
6848.44
Net Income per Share
-1552.29
Price to Earning Ratio
-5.83x
Price To Sales Ratio
1.44x
POCF Ratio
-20.07
PFCF Ratio
-9.7
Price to Book Ratio
0.96
EV to Sales
1.17
EV Over EBITDA
-10.13
EV to Operating CashFlow
-17.79
EV to FreeCashFlow
-7.88
Earnings Yield
-0.17
FreeCashFlow Yield
-0.1
Market Cap
159,31 Bil.
Enterprise Value
129,48 Bil.
Graham Number
18135.43
Graham NetNet
32.85

Income Statement Metrics

Net Income per Share
-1552.29
Income Quality
0.29
ROE
-0.16
Return On Assets
-0.2
Return On Capital Employed
-0.18
Net Income per EBT
0.99
EBT Per Ebit
1.14
Ebit per Revenue
-0.58
Effective Tax Rate
0.01

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0.01
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.12
Operating Profit Margin
-0.58
Pretax Profit Margin
-0.66
Net Profit Margin
-0.65

Dividends

Dividend Yield
0.01
Dividend Yield %
1.1
Payout Ratio
-0.06
Dividend Per Share
100

Operating Metrics

Operating Cashflow per Share
-450.89
Free CashFlow per Share
-1017.59
Capex to Operating CashFlow
1.26
Capex to Revenue
-0.08
Capex to Depreciation
-1.39
Return on Invested Capital
-0.14
Return on Tangible Assets
-0.12
Days Sales Outstanding
38.78
Days Payables Outstanding
29.19
Days of Inventory on Hand
161.39
Receivables Turnover
9.41
Payables Turnover
12.5
Inventory Turnover
2.26
Capex per Share
-566.7

Balance Sheet

Cash per Share
1.847,78
Book Value per Share
9.416,75
Tangible Book Value per Share
9193.89
Shareholders Equity per Share
9416.75
Interest Debt per Share
126.22
Debt to Equity
0.01
Debt to Assets
0.01
Net Debt to EBITDA
2.33
Current Ratio
2.23
Tangible Asset Value
148,40 Bil.
Net Current Asset Value
62,63 Bil.
Invested Capital
0.01
Working Capital
69,33 Bil.
Intangibles to Total Assets
0.02
Average Receivables
11,04 Bil.
Average Payables
9,54 Bil.
Average Inventory
44233848340
Debt to Market Cap
0.01

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

ICD Co., Ltd. Dividends
Year Dividends Growth
2014 100
2016 100 0%
2022 100 0%

ICD Co., Ltd. Profile

About ICD Co., Ltd.

ICD Co., Ltd. engages in the manufacture and sale of LCD, semiconductor, and flat panel display equipment in South Korea and internationally. The company offers AMOLED equipment, including HDP etchers, dry etchers, plasma treatment systems, and evaporators; and TFT-LCD equipment comprising dry etchers and plasma ashers. It also provides parts, such as electrostatic chucks, high voltage DC generators, end point detectors, 3D glass forming systems, and surface treatment parts. The company was founded in 2000 and is headquartered in Anseong, South Korea.

CEO
Mr. Seung-Ho Lee
Employee
297
Address
274, Manse-ro
Anseong-si, 456-833

ICD Co., Ltd. Executives & BODs

ICD Co., Ltd. Executives & BODs
# Name Age
1 Mr. Jeong-Beom Yeo
Chief Technology Officer and Director
70
2 Kyung-Hwan Jang
Chief of R&D Center Laboratory and Director
70
3 Mr. Seung-Ho Lee
Chief Executive Officer and Director
70
4 Chan-Man Jung
Managing Director, Head of Solution Center and Director
70
5 Mr. Myung-Ho Kim
CPO and Director
70

ICD Co., Ltd. Competitors

SFA Engineering Corporation Logo
SFA Engineering Corporation

056190.KQ

(0.0)
KC Co., Ltd. Logo
KC Co., Ltd.

029460.KS

(2.5)